EP1214079A4 - Arzneimittel zur behandlung von frakturen - Google Patents
Arzneimittel zur behandlung von frakturenInfo
- Publication number
- EP1214079A4 EP1214079A4 EP00952791A EP00952791A EP1214079A4 EP 1214079 A4 EP1214079 A4 EP 1214079A4 EP 00952791 A EP00952791 A EP 00952791A EP 00952791 A EP00952791 A EP 00952791A EP 1214079 A4 EP1214079 A4 EP 1214079A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- drug
- treating fractures
- fractures
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ232599 | 1999-08-19 | ||
AUPQ2325A AUPQ232599A0 (en) | 1999-08-19 | 1999-08-19 | Drug for treating fractures |
PCT/AU2000/000982 WO2001013922A1 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1214079A1 EP1214079A1 (de) | 2002-06-19 |
EP1214079A4 true EP1214079A4 (de) | 2004-03-24 |
Family
ID=3816500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00952791A Withdrawn EP1214079A4 (de) | 1999-08-19 | 2000-08-17 | Arzneimittel zur behandlung von frakturen |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1214079A4 (de) |
JP (1) | JP2003507426A (de) |
KR (1) | KR20020027562A (de) |
CN (1) | CN100345548C (de) |
AU (1) | AUPQ232599A0 (de) |
BR (1) | BR0013416A (de) |
CA (1) | CA2381302A1 (de) |
HK (1) | HK1048441B (de) |
HU (1) | HUP0202396A3 (de) |
IL (1) | IL148166A0 (de) |
NO (1) | NO20020784D0 (de) |
NZ (1) | NZ517538A (de) |
PL (1) | PL353485A1 (de) |
SK (1) | SK2382002A3 (de) |
WO (1) | WO2001013922A1 (de) |
ZA (1) | ZA200202160B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1233325C (zh) | 2001-02-06 | 2005-12-28 | 罗亚尔·亚历山德拉儿童医院 | 治疗骨坏死和处理有发展为骨坏死危险的患者用的药物 |
US20040157798A1 (en) * | 2001-04-03 | 2004-08-12 | Little David Graham | Drug for use in bone grafting |
AUPR553701A0 (en) * | 2001-06-07 | 2001-07-12 | Royal Alexandra Hospital For Children, The | A device for the delivery of a drug to a fractured bone |
ES2561463T3 (es) * | 2003-08-21 | 2016-02-26 | Addbio Ab | Dispositivo de implante recubierto con bisfosfonato y método para el mismo |
CA2539359A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
ITMI20040218A1 (it) * | 2004-02-10 | 2004-05-10 | Abiogen Pharma Spa | Uso di neridronato sodico per promuovere la neoformazione ossea |
ITMI20040641A1 (it) * | 2004-03-31 | 2004-06-30 | Tb Technology S R L | Composizioni bioadesive bifunzionali per implantologia orale |
AR048742A1 (es) * | 2004-12-22 | 2006-05-24 | Gador Sa | Sistema de aplicacion de medicamentos intra-oral |
ES2379485T3 (es) * | 2005-10-27 | 2012-04-26 | Thommen Medical Ag | Implante dental y procedimiento para su fabricación |
US8882740B2 (en) | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
CN114532937A (zh) * | 2020-11-18 | 2022-05-27 | 中国人民解放军海军军医大学第一附属医院 | 一种小肠镜辅助装置 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530360A (en) * | 1981-11-19 | 1985-07-23 | Duarte Luiz R | Method for healing bone fractures with ultrasound |
EP0600834A1 (de) * | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Verwendung von Methanbiphosphonsäurederivaten zur Herstellung eines Arzneimittels zur Behandlung von Knochenbrüchen |
WO1994014455A1 (en) * | 1992-12-23 | 1994-07-07 | Merck & Co., Inc. | Bisphosphonate/estrogen therapy for treating and preventing bone loss |
WO1995030421A1 (en) * | 1994-05-04 | 1995-11-16 | Ciba-Geigy Ag | Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993011786A1 (en) * | 1991-12-17 | 1993-06-24 | Procter & Gamble Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
AU670337B2 (en) * | 1992-11-30 | 1996-07-11 | Novartis Ag | Use of certain methanebisphosphonic acid derivatives in fracture healing |
US5403829A (en) * | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
CA2221416A1 (en) * | 1995-06-06 | 1996-12-12 | Merck & Co., Inc. | Bisphosphonate therapy for bone loss associated with rheumatoid arthritis |
US5616571A (en) * | 1995-06-06 | 1997-04-01 | Merck & Co., Inc. | Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
US5853759A (en) * | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
GB9613722D0 (en) * | 1996-06-28 | 1996-08-28 | Univ Liverpool | Chemical compounds |
-
1999
- 1999-08-19 AU AUPQ2325A patent/AUPQ232599A0/en not_active Abandoned
-
2000
- 2000-08-17 CA CA002381302A patent/CA2381302A1/en not_active Abandoned
- 2000-08-17 EP EP00952791A patent/EP1214079A4/de not_active Withdrawn
- 2000-08-17 PL PL00353485A patent/PL353485A1/xx not_active Application Discontinuation
- 2000-08-17 JP JP2001518059A patent/JP2003507426A/ja active Pending
- 2000-08-17 HU HU0202396A patent/HUP0202396A3/hu unknown
- 2000-08-17 KR KR1020027002160A patent/KR20020027562A/ko not_active Application Discontinuation
- 2000-08-17 SK SK238-2002A patent/SK2382002A3/sk not_active Application Discontinuation
- 2000-08-17 NZ NZ517538A patent/NZ517538A/en unknown
- 2000-08-17 BR BR0013416-3A patent/BR0013416A/pt not_active Application Discontinuation
- 2000-08-17 IL IL14816600A patent/IL148166A0/xx unknown
- 2000-08-17 WO PCT/AU2000/000982 patent/WO2001013922A1/en active IP Right Grant
- 2000-08-17 CN CNB008117659A patent/CN100345548C/zh not_active Expired - Fee Related
-
2002
- 2002-02-18 NO NO20020784A patent/NO20020784D0/no not_active Application Discontinuation
- 2002-03-15 ZA ZA200202160A patent/ZA200202160B/en unknown
-
2003
- 2003-01-21 HK HK03100502.8A patent/HK1048441B/zh not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530360A (en) * | 1981-11-19 | 1985-07-23 | Duarte Luiz R | Method for healing bone fractures with ultrasound |
EP0600834A1 (de) * | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Verwendung von Methanbiphosphonsäurederivaten zur Herstellung eines Arzneimittels zur Behandlung von Knochenbrüchen |
WO1994014455A1 (en) * | 1992-12-23 | 1994-07-07 | Merck & Co., Inc. | Bisphosphonate/estrogen therapy for treating and preventing bone loss |
WO1995030421A1 (en) * | 1994-05-04 | 1995-11-16 | Ciba-Geigy Ag | Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration |
Non-Patent Citations (4)
Title |
---|
DENISSEN H ET AL: "CERAMIC HYDROXYAPATITE IMPLANTS FOR THE RELEASE OF BIPHOSPHONATE", BONE AND MINERAL, SHANNON, IE, vol. 25, no. 2, 1994, pages 123 - 134, XP001015353 * |
ECK J. ET AL: "Diagnosis and Treatment of Common Metabolic Spinal Disorders in the Geriatric Population", SOUTHERN MEDICAL JOURNAL, vol. 91, no. 12, 1998, pages 1089 - 1097, XP002906300 * |
SABOKBAR A. ET AL: "Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption", ANNALS OF RHEUMATIC DISEASES, vol. 57, no. 10, 1998, pages 614 - 618, XP002953301, DOI: 10.1136/ard.57.10.614 * |
See also references of WO0113922A1 * |
Also Published As
Publication number | Publication date |
---|---|
IL148166A0 (en) | 2002-09-12 |
BR0013416A (pt) | 2002-04-30 |
NO20020784L (no) | 2002-02-18 |
HUP0202396A3 (en) | 2005-02-28 |
EP1214079A1 (de) | 2002-06-19 |
NO20020784D0 (no) | 2002-02-18 |
CN100345548C (zh) | 2007-10-31 |
HK1048441A1 (en) | 2003-04-04 |
CA2381302A1 (en) | 2001-03-01 |
SK2382002A3 (en) | 2002-09-10 |
KR20020027562A (ko) | 2002-04-13 |
WO2001013922A1 (en) | 2001-03-01 |
HK1048441B (zh) | 2008-02-22 |
JP2003507426A (ja) | 2003-02-25 |
NZ517538A (en) | 2003-07-25 |
ZA200202160B (en) | 2003-08-27 |
PL353485A1 (en) | 2003-11-17 |
CN1370071A (zh) | 2002-09-18 |
AUPQ232599A0 (en) | 1999-09-09 |
HUP0202396A2 (hu) | 2002-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0200556A3 (en) | Medicament for treating diabetes | |
HK1200316A1 (en) | Therapeutic microfoams | |
IL138784A0 (en) | Treatment for diabetes | |
PL350167A1 (en) | Medicament for treating hypertension | |
GB9930570D0 (en) | Therapy | |
GB9925136D0 (en) | Novel treatment | |
GB9907243D0 (en) | Therapy | |
IL148166A0 (en) | Drug for treating fractures | |
PL349347A1 (en) | Novel treatment | |
GB9900222D0 (en) | Therapeutic compounds | |
HU9902296D0 (en) | Pharmaceutical composition for treating caltification | |
GB0020261D0 (en) | Therapeutic treatment | |
HUP0105469A3 (en) | Therapeutic drugs comprising pyrroloazepines for treating intermittent claudication | |
GB9901505D0 (en) | Therapeutic treatment | |
GB9918785D0 (en) | Therapeutic treatment | |
HU9904711D0 (en) | Set for fixation fractures | |
GB9919721D0 (en) | Medical apparatus | |
GB9908993D0 (en) | Treatment | |
GB9903558D0 (en) | Medical treatment | |
GB9923343D0 (en) | Treatment system | |
GB9924712D0 (en) | Therapeutic method | |
AU142194S (en) | Medical treatment apparatus | |
GB9927106D0 (en) | Cancer treatment | |
GB9908176D0 (en) | Cancer treatment | |
GB9909650D0 (en) | Novel treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020314 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20020313 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040205 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 19/00 B Ipc: 7A 61K 31/663 A Ipc: 7A 61K 31/675 B |
|
17Q | First examination report despatched |
Effective date: 20041008 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20080903 |